157 related articles for article (PubMed ID: 29750737)
1. Interindividual and Intraindividual Variation of Methylphenidate Concentrations in Serum and Saliva of Patients With Attention-Deficit/Hyperactivity Disorder.
Preiskorn J; Studer S; Rauh R; Lukačin R; Geffert C; Fleischhaker C; Clement HW; Schulz E; Biscaldi M
Ther Drug Monit; 2018 Aug; 40(4):435-442. PubMed ID: 29750737
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
[TBL] [Abstract][Full Text] [Related]
3. Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.
Stevens JR; George RA; Fusillo S; Stern TA; Wilens TE
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):49-54. PubMed ID: 20166796
[TBL] [Abstract][Full Text] [Related]
4. Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Yorbik O; Mutlu C; Ozilhan S; Eryilmaz G; Isiten N; Alparslan S; Saglam E
Ther Drug Monit; 2015 Jun; 37(3):347-52. PubMed ID: 25384118
[TBL] [Abstract][Full Text] [Related]
5. A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR
Adjei AL; Chaudhary I; Kollins SH; Padilla A
Paediatr Drugs; 2020 Oct; 22(5):561-570. PubMed ID: 32776159
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage.
Chermá MD; Josefsson M; Rydberg I; Woxler P; Trygg T; Hollertz O; Gustafsson PA
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):295-307. PubMed ID: 27220743
[TBL] [Abstract][Full Text] [Related]
7. Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry.
Seçilir A; Schrier L; Bijleveld YA; Toersche JH; Jorjani S; Burggraaf J; van Gerven J; Mathôt RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():22-8. PubMed ID: 23454305
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.
Arvidsson M; Franck J; Ackehed G; Pettersson Bergstrand M; Ekström L; Rosenborg S; Dahl ML
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):492-500. PubMed ID: 35040257
[TBL] [Abstract][Full Text] [Related]
10. HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection.
Wada M; Abe K; Ikeda R; Kikura-Hanajiri R; Kuroda N; Nakashima K
Anal Bioanal Chem; 2011 Apr; 400(2):387-93. PubMed ID: 21318251
[TBL] [Abstract][Full Text] [Related]
11. Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder.
Jonkman LM; Verbaten MN; de Boer D; Maes RA; Buitelaar JK; Kemner C; van Engeland H; Koelega HS
Psychiatry Res; 1998 Mar; 78(1-2):115-8. PubMed ID: 9579707
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
Wigal SB; Gupta S; Heverin E; Starr HL
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitative analysis of methylphenidate and ritalinic acid in oral fluid by liquid chromatography triple quadrupole mass spectrometry (LC-QqQ-MS).
Mulet CT; Arroyo-Mora LE; Leon LA; Gnagy E; DeCaprio AP
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():313-319. PubMed ID: 29935479
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of methylphenidate and ritalinic acid in hair using LC-MS/MS.
Jang M; Kim J; Shin I; Kang S; Choi H; Yang W
Forensic Sci Int; 2019 Jan; 294():183-188. PubMed ID: 30530155
[TBL] [Abstract][Full Text] [Related]
15. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
16. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
17. Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment.
Beck O; Stephanson N; Sandqvist S; Franck J
Ther Drug Monit; 2014 Aug; 36(4):528-34. PubMed ID: 24452069
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
Teicher MH; Polcari A; Foley M; Valente E; McGreenery CE; Chang WW; McKay G; Midha KK
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
[TBL] [Abstract][Full Text] [Related]
19. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
20. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
